Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas Winder

Showing results (71-80 of 92) with videos related to

Pageof 10
Sort By:
Journal of Clinical Medicine|April 3, 2020
Local and Central Evaluation of HER2 Positivity and Clinical Outcome in Advanced Gastric and Gastroesophageal Cancer-Results from the AGMT GASTRIC-5 RegistryFlorian Huemer, Lukas Weiss, Peter Regitnig, et al.
Plos One|April 22, 2017
Risk stratification for venous thromboembolism in patients with testicular germ cell tumorsAngelika Bezan, Florian Posch, Ferdinand Ploner, et al.
Future Oncology (London, England)|March 20, 2026
AGMT mCRC Registry Third-Line and Beyond: a multicentric real-world platform with integrated imaging and biosample database for later-line metastatic colorectal cancerFlorian Huemer, Gudrun Piringer, Wolfgang Eisterer, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 28, 2011
Pharmacogenetic angiogenesis profiling for first-line Bevacizumab plus oxaliplatin-based chemotherapy in patients with metastatic colorectal cancerArmin Gerger, Anthony El-Khoueiry, Wu Zhang, et al.
BMJ Open|May 25, 2022
SARS-CoV-2 RBD-specific and NP-specific antibody response of healthcare workers in the westernmost Austrian state Vorarlberg: a prospective cohort studyMichele Atzl, Axel Muendlein, Thomas Winder, et al.
Plos One|November 10, 2017
SOX9 is a proliferation and stem cell factor in hepatocellular carcinoma and possess widespread prognostic significance in different cancer typesGeorg Richtig, Ariane Aigelsreiter, Daniela Schwarzenbacher, et al.
Annals of Surgery|January 27, 2010
Genetic variations in angiogenesis pathway genes predict tumor recurrence in localized adenocarcinoma of the esophagusGeorg Lurje, Jessica M Leers, Alexandra Pohl, et al.
Scientific Reports|April 5, 2019
Benefit of second-line systemic chemotherapy for advanced biliary tract cancer: A propensity score analysisFlorian Moik, Jakob M Riedl, Thomas Winder, et al.
Oncoimmunology|February 9, 2018
Maturation of tertiary lymphoid structures and recurrence of stage II and III colorectal cancerFlorian Posch, Karina Silina, Sebastian Leibl, et al.
Cancers|April 26, 2025
Real-World Data on the Efficacy of Daratumumab in Patients with Relapsed/Refractory Multiple Myeloma and Amplification 1qMagdalena Benda, Patrick Reimann, Elena Bletzacher, et al.
Pageof 10

Showing results (71-80 of 92) with videos related to

Sort By:
Pageof 10
Journal of Clinical Medicine|April 3, 2020
Local and Central Evaluation of HER2 Positivity and Clinical Outcome in Advanced Gastric and Gastroesophageal Cancer-Results from the AGMT GASTRIC-5 RegistryFlorian Huemer, Lukas Weiss, Peter Regitnig, et al.
Plos One|April 22, 2017
Risk stratification for venous thromboembolism in patients with testicular germ cell tumorsAngelika Bezan, Florian Posch, Ferdinand Ploner, et al.
Future Oncology (London, England)|March 20, 2026
AGMT mCRC Registry Third-Line and Beyond: a multicentric real-world platform with integrated imaging and biosample database for later-line metastatic colorectal cancerFlorian Huemer, Gudrun Piringer, Wolfgang Eisterer, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 28, 2011
Pharmacogenetic angiogenesis profiling for first-line Bevacizumab plus oxaliplatin-based chemotherapy in patients with metastatic colorectal cancerArmin Gerger, Anthony El-Khoueiry, Wu Zhang, et al.
BMJ Open|May 25, 2022
SARS-CoV-2 RBD-specific and NP-specific antibody response of healthcare workers in the westernmost Austrian state Vorarlberg: a prospective cohort studyMichele Atzl, Axel Muendlein, Thomas Winder, et al.
Plos One|November 10, 2017
SOX9 is a proliferation and stem cell factor in hepatocellular carcinoma and possess widespread prognostic significance in different cancer typesGeorg Richtig, Ariane Aigelsreiter, Daniela Schwarzenbacher, et al.
Annals of Surgery|January 27, 2010
Genetic variations in angiogenesis pathway genes predict tumor recurrence in localized adenocarcinoma of the esophagusGeorg Lurje, Jessica M Leers, Alexandra Pohl, et al.
Scientific Reports|April 5, 2019
Benefit of second-line systemic chemotherapy for advanced biliary tract cancer: A propensity score analysisFlorian Moik, Jakob M Riedl, Thomas Winder, et al.
Oncoimmunology|February 9, 2018
Maturation of tertiary lymphoid structures and recurrence of stage II and III colorectal cancerFlorian Posch, Karina Silina, Sebastian Leibl, et al.
Cancers|April 26, 2025
Real-World Data on the Efficacy of Daratumumab in Patients with Relapsed/Refractory Multiple Myeloma and Amplification 1qMagdalena Benda, Patrick Reimann, Elena Bletzacher, et al.
Pageof 10